The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents
Platinum-based anticancer drugs, including cisplatin, carboplatin, oxaliplatin, nedaplatin, and lobaplatin, are heavily applied in chemotherapy regimens. However, the intrinsic or acquired resistance severely limit the clinical application of platinum-based treatment. The underlying mechanisms are i...
Saved in:
Main Authors: | Jiabei Zhou (Author), Yu Kang (Author), Lu Chen (Author), Hua Wang (Author), Junqing Liu (Author), Su Zeng (Author), Lushan Yu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Research and development of drug delivery systems based on drug transporter and nano-formulation
by: Yi Peng, et al.
Published: (2020) -
Progress in the study of reproductive toxicity of platinum-based antitumor drugs and their means of prevention
by: Zhan Jin, et al.
Published: (2024) -
Structural Optimization of Platinum Drugs to Improve the Drug-Loading and Antitumor Efficacy of PLGA Nanoparticles
by: Maria B. Sokol, et al.
Published: (2022) -
Synthesis and evaluation of platinum complexes with potential antitumor activity
by: Rachel Lima Marcelino Freire, et al.
Published: (2017) -
Non-coding RNA-related antitumor mechanisms of marine-derived agents
by: Zhixia Zhou, et al.
Published: (2022)